Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.

Suppr

超能文献

作者信息

Pope E, Chakkittakandiyil A, Lara-Corrales I, Maki E, Weinstein M

出版信息

Br J Dermatol. 2013 Jan;168(1):222-4. doi: 10.1111/j.1365-2133.2012.11131.x. Epub 2012 Oct 5.

DOI:10.1111/j.1365-2133.2012.11131.x

PMID:22762503

Abstract

摘要

相似文献

Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.

Br J Dermatol. 2013 Jan;168(1):222-4. doi: 10.1111/j.1365-2133.2012.11131.x. Epub 2012 Oct 5.

Propranolol for infantile haemangiomas: a review.

Arch Dis Child. 2011 Sep;96(9):890-3. doi: 10.1136/adc.2010.208884. Epub 2011 May 28.

Propranolol for treatment of ulcerated infantile hemangiomas.

J Am Acad Dermatol. 2011 May;64(5):827-32. doi: 10.1016/j.jaad.2010.12.040. Epub 2011 Feb 25.

Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.

J Am Acad Dermatol. 2011 May;64(5):833-8. doi: 10.1016/j.jaad.2011.01.025. Epub 2011 Feb 25.

β-blockers for infantile hemangiomas: a single-institution experience.

Clin Pediatr (Phila). 2011 Aug;50(8):757-63. doi: 10.1177/0009922811405517. Epub 2011 Apr 27.

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

Laryngoscope. 2010 Apr;120(4):676-81. doi: 10.1002/lary.20807.

[Use of beta blockers--a new perspective in therapy of infantile hemangiomas of the head and neck area].

Laryngorhinootologie. 2010 Apr;89(4):230-1. doi: 10.1055/s-0029-1237351. Epub 2009 Sep 2.

[Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].

Lakartidningen. 2013;110(19-20):942-5.

Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.

Br J Dermatol. 2013 Jul;169(1):181-3. doi: 10.1111/bjd.12217.

Beta-blockers no better than placebo in the treatment of vasovagal syncope.

J Fam Pract. 2002 Nov;51(11):921.

引用本文的文献

IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI).

Indian Dermatol Online J. 2023 Mar 3;14(2):172-186. doi: 10.4103/idoj.idoj_52_22. eCollection 2023 Mar-Apr.

Paediatrics: how to manage infantile haemangioma.

Drugs Context. 2021 Apr 6;10. doi: 10.7573/dic.2020-12-6. eCollection 2021.

Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients.

Ann Transl Med. 2021 Jan;9(2):116. doi: 10.21037/atm-20-5359.

Progress in the treatment of infantile hemangioma.

Ann Transl Med. 2019 Nov;7(22):692. doi: 10.21037/atm.2019.10.47.

Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.

Pan Afr Med J. 2019 Apr 8;32:155. doi: 10.11604/pamj.2019.32.155.16760. eCollection 2019.

Central Effects of Beta-Blockers May Be Due to Nitric Oxide and Hydrogen Peroxide Release Independently of Their Ability to Cross the Blood-Brain Barrier.

Front Neurosci. 2019 Jan 31;13:33. doi: 10.3389/fnins.2019.00033. eCollection 2019.

Interventions for infantile haemangiomas of the skin.

Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.

Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.

Sci Rep. 2018 Mar 9;8(1):4264. doi: 10.1038/s41598-018-22787-8.

[Research progresses in the pathogenesis, diagnosis and treatment of infantile hemangioma with PHACE syndrome].

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Dec;19(12):1291-1296. doi: 10.7499/j.issn.1008-8830.2017.12.013.

Advances in the Medical Management of Vascular Anomalies.

Semin Intervent Radiol. 2017 Sep;34(3):239-249. doi: 10.1055/s-0037-1604297. Epub 2017 Sep 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验